811. Immunomodulators for Rheumatologic Diseases
Session: Symposium: Friendly Fire—Immunotherapies and Infectious Diseases
Thursday, October 27, 2016: 2:00 PM
Room: Theater A & B
Kevin L. Winthrop, MD, MPH, Oregon Health & Science University, Portland, OR


Disclosures:

K. L. Winthrop, Pfizer: Grant Investigator , Research grant
Bristol Myers Squibb: Grant Investigator , Research grant
Pfizer: Consultant , Consulting fee
Bristol Myers Squibb: Consultant , Consulting fee
Lilly: Consultant , Consulting fee
Amgen: Consultant , Consulting fee
Abbvie: Consultant , Consulting fee
UCB: Consultant , Consulting fee

Previous Presentation | Next Presentation >>

Findings in the abstracts are embargoed until 12:01 a.m. CDT, Wednesday Oct. 26th with the exception of research findings presented at the IDWeek press conferences.